Literature DB >> 10394310

Health care worker disability due to latex allergy and asthma: a cost analysis.

V L Phillips1, M A Goodrich, T J Sullivan.   

Abstract

OBJECTIVES: The reported prevalence of occupational allergy to natural rubber latex is 8% to 17%, and that of latex-induced occupational asthma is 2.5% to 6%. Conversion of medical facilities to "latex-safe" can reduce employee sensitization, impairment, and disability. The purpose of this study was to determine the cost of a latex-safe approach, compared with that of continued latex glove use, and to identify the level of worker disability required to make the latex-safe approach financially preferable to a health care institution.
METHODS: The costs of 2 strategies--latex-safe vs the status quo--were calculated from the perspective of 3 health care institutions. A break-even point was calculated for each facility.
RESULTS: In all facilities, the cost of using nonlatex gloves exceeded the cost of using latex gloves. In all 3 facilities, however, 1% or fewer of those at risk would have to become fully disabled or fewer than 2% would have to become partially disabled for the continued use of latex gloves to exceed the cost of the latex-safe approach.
CONCLUSION: Health care facilities, regardless of size, are likely to benefit financially from becoming latex-safe even if latex-related disability levels are extremely low.

Entities:  

Mesh:

Year:  1999        PMID: 10394310      PMCID: PMC1508827          DOI: 10.2105/ajph.89.7.1024

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  17 in total

1.  Prevalence of latex allergy in operating room nurses.

Authors:  F Lagier; D Vervloet; I Lhermet; D Poyen; D Charpin
Journal:  J Allergy Clin Immunol       Date:  1992-09       Impact factor: 10.793

2.  Prevalence of latex sensitization among hospital physicians occupationally exposed to latex gloves.

Authors:  R Arellano; J Bradley; G Sussman
Journal:  Anesthesiology       Date:  1992-11       Impact factor: 7.892

3.  Surgical glove powders bind latex antigens.

Authors:  D Beezhold; W C Beck
Journal:  Arch Surg       Date:  1992-11

4.  Surgical gloves. Measuring cost and barrier effectiveness.

Authors:  M F Fay; D T Dooher
Journal:  AORN J       Date:  1992-06       Impact factor: 0.676

5.  Fate of occupational asthma. A follow-up study of patients with occupational asthma due to Western Red Cedar (Thuja plicata).

Authors:  M Chan-Yeung
Journal:  Am Rev Respir Dis       Date:  1977-12

6.  Extractable latex allergens and proteins in disposable medical gloves and other rubber products.

Authors:  J W Yunginger; R T Jones; A F Fransway; J M Kelso; M A Warner; L W Hunt
Journal:  J Allergy Clin Immunol       Date:  1994-05       Impact factor: 10.793

7.  Cornstarch powder on latex products is an allergen carrier.

Authors:  V J Tomazic; E L Shampaine; A Lamanna; T J Withrow; N F Adkinson; R G Hamilton
Journal:  J Allergy Clin Immunol       Date:  1994-04       Impact factor: 10.793

Review 8.  Permeability of latex and thermoplastic elastomer gloves to the bacteriophage phi X174.

Authors:  C P Hamann; J R Nelson
Journal:  Am J Infect Control       Date:  1993-12       Impact factor: 2.918

9.  A medical-center-wide, multidisciplinary approach to the problem of natural rubber latex allergy.

Authors:  L W Hunt; J L Boone-Orke; A F Fransway; C E Fremstad; R T Jones; M C Swanson; M T McEvoy; L K Miller; E T Majerus; P A Luker; D L Scheppmann; M J Webb; J W Yunginger
Journal:  J Occup Environ Med       Date:  1996-08       Impact factor: 2.162

10.  Latex allergy in hospital employees.

Authors:  M S Yassin; M B Lierl; T J Fischer; K O'Brien; J Cross; C Steinmetz
Journal:  Ann Allergy       Date:  1994-03
View more
  2 in total

1.  Grand rounds: latex-induced occupational asthma in a surgical pathologist.

Authors:  Judith Green-McKenzie; Debra Hudes
Journal:  Environ Health Perspect       Date:  2005-07       Impact factor: 9.031

2.  Occupational allergy to β-lactam antibiotics.

Authors:  Anna Classen; Thomas Fuchs
Journal:  Allergo J Int       Date:  2015-03-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.